Tilray Insiders Are Selling Stock………Again.

In late July, Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY) released fourth quarter financial results and the market responded favorably to the numbers.

This was the first quarterly earnings report following the completion of a merger with Aphria, a leading Canadian and international cannabis company, and we believe the combined company is well positioned to capitalize on attractive verticals of the industry.

One of the key impacts from the Aphria merger is related to the management team. After the deal was completed, former Tilray CEO Brendan Kennedy took a backseat to Irwin Simon who was appointed as CEO of the combined company.

Since then, Kennedy has been selling large amounts of stock in accordance with Rule 10b5-1. Last week, Kennedy completed two transactions and sold 600,000 common shares, in aggregate, at a range of prices (from $14.08 to $14.46).

In June, Kennedy started to sell stock as a result of his previously filed Rule 10b5-1 trading plan and has sold 1.6 million shares since then. Following the recent stock sales, he still owns more than 7.9 million shares and is still one of Tilray’s largest shareholders.

At current levels, Tilray is valued at more than $6.6 billion (by market capitalization on August 11^th). Going forward, we are highly focused on how the management team continues to execute on the domestic and international cannabis opportunity and believe the business is well positioned for growth.

One of the most exciting aspects of the Tilray story is related to its focus on the US market. The combined company owns strategic non-cannabis assets in the US and is well positioned to capitalize on the cannabis market once federal legislation changes.

From cannabis beverages to hemp based products, we believe that Tilray has significant potential catalysts for growth. We are favorable on how the management team has been driving the story forward and will monitor how the business continues to advance.

We believe that Tilray is executing on a multi-national expansion strategy and are bullish on the growth prospects that are associated with it. If you are interested in learning more about Tilray, please send an email to support@technical420.com with the subject “Tilray” to be added to our distribution list.

For the fastest access to data on Tilray, sign up for our free newsletter!

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Top Stories